Vestmark Advisory Solutions, Inc. Abb Vie Inc. Transaction History

Vestmark Advisory Solutions, Inc.

$2.43 Billion
Q3 2024

A detailed history of Vestmark Advisory Solutions, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Vestmark Advisory Solutions, Inc. holds 18,595 shares of ABBV stock, worth $3.17 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

18,595

Previous 24,711 24.75%

Holding current value

$3.17 Million

Previous $4.24 Million 13.36%

% of portfolio

0.15%

Previous 0.19%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $1 Million - $1.22 Million	-6,116 Reduced 24.75%	18,595 $3.67 Million
Q2 2024 Aug 12, 2024	BUY	$154.79 - $180.76 $948,707 - $1.11 Million	6,129 Added 32.98%	24,711 $4.24 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $138,084 - $157,334	-864 Reduced 4.44%	18,582 $3.38 Million
Q4 2023 Feb 06, 2024	SELL	$137.6 - $154.97 $200,758 - $226,101	-1,459 Reduced 6.98%	19,446 $3.01 Million
Q3 2023 Nov 06, 2023	SELL	$133.59 - $154.65 $7.91 Million - $9.16 Million	-59,248 Reduced 73.92%	20,905 $3.12 Million
Q2 2023 Aug 07, 2023	BUY	$132.51 - $164.9 $262,369 - $326,502	1,980 Added 2.53%	80,153 $10.8 Million
Q1 2023 May 09, 2023	SELL	$144.61 - $166.54 $106,722 - $122,906	-738 Reduced 0.94%	78,173 $12.5 Million
Q4 2022 Jan 20, 2023	BUY	$138.31 - $165.87 $54,770 - $65,684	396 Added 0.5%	78,911 $0
Q3 2022 Nov 03, 2022	BUY	$134.21 - $153.93 $1.02 Million - $1.17 Million	7,631 Added 10.77%	78,515 $10.5 Million
Q2 2022 Aug 04, 2022	BUY	$137.62 - $174.96 $1.61 Million - $2.05 Million	11,724 Added 19.82%	70,884 $10.9 Million
Q1 2022 Apr 27, 2022	BUY	$131.98 - $163.75 $450,447 - $558,878	3,413 Added 6.12%	59,160 $9.59 Million
Q4 2021 Jan 31, 2022	BUY	$107.43 - $135.93 $236,990 - $299,861	2,206 Added 4.12%	55,747 $7.55 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $1.13 Million - $1.28 Million	10,606 Added 24.7%	53,541 $5.78 Million
Q2 2021 Aug 09, 2021	BUY	$105.21 - $117.21 $132,564 - $147,684	1,260 Added 3.02%	42,935 $4.84 Million
Q1 2021 May 10, 2021	BUY	$102.3 - $112.62 $220,354 - $242,583	2,154 Added 5.45%	41,675 $4.51 Million
Q4 2020 Feb 04, 2021	BUY	$80.49 - $108.67 $18,351 - $24,776	228 Added 0.58%	39,521 $4.24 Million
Q3 2020 Oct 19, 2020	BUY	$85.91 - $100.83 $224,654 - $263,670	2,615 Added 7.13%	39,293 $3.44 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $1.32 Million - $1.76 Million	17,974 Added 96.1%	36,678 $3.6 Million
Q1 2020 May 06, 2020	BUY	$64.5 - $97.79 $96,040 - $145,609	1,489 Added 8.65%	18,704 $1.43 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $21,061 - $26,353	292 Added 1.73%	17,215 $1.52 Million
Q3 2019 Nov 05, 2019	BUY	$62.98 - $75.72 $275,978 - $331,805	4,382 Added 34.94%	16,923 $1.28 Million
Q2 2019 Aug 20, 2019	BUY	$65.7 - $83.98 $16,293 - $20,827	248 Added 2.02%	12,541 $912,000
Q1 2019 May 14, 2019	BUY	$77.14 - $90.79 $948,282 - $1.12 Million	12,293 New	12,293 $991,000

Others Institutions Holding ABBV

# of Institutions

3,817

Shares Held

1.25B

Call Options Held

13M

Put Options Held

10M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $301B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestmark Advisory Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vestmark Advisory Solutions, Inc. with notifications on news.

Account

Vestmark Advisory Solutions, Inc. Abb Vie Inc. Transaction History